STAT Plus: A drug maker replaces an old treatment and boosts the price by 1,300%
The Trump administration may brag that drug makers are dialing back price hikes, but a company that makes the only essential mineral used by hospitals for feeding patients intravenously recently raised its price by a whopping 1,300%.
Last month, American Regent began selling a product called Selenious Acid Injection, which is used for total parenteral nutrition, a way to provide nutrients to patients who cannot eat food. Selenious Acid is an updated version of an older product called Selenium which, along with numerous other decades-old medicines, had never actually been approved by the Food and Drug Administration.
